Abstract 3113
Background
Neuroendocrine tumours (NET) associated with the gastrointestinal tract are frequently indolent but problematic as a result of potential endocrine secretory properties and metastasis often to the liver. Metastases (mNET) located in the midgut and liver often secrete vasoactive products, giving rise to the “carcinoid Syndrome,”; flushing, diarrhoea, wheezing, abdominal cramps and peripheral oedema. Treatment options for mNET include surgical resection, chemoablation, and use somatostatin analogues (e.g. octreotide, lantreotide) or radio-labelled analogues (e.g. Lutate/Lutathera, 177Lu DOTA-octreotate). However there is a need for additional options for mNET patients. There has been a paradigm shift in anti-cancer therapy over the last decade with the introduction of immunotherapy treatments. Intralesional rose bengal disodium (PV-10) is undergoing clinical development as an oncolytic immunotherapy and is the subject of this phase 1 study examining potential use of PV-10 for treatment of symptomatic mNET of the liver (NCT02693067).
Trial design
This phase 1 study is evaluating the safety, tolerability and reduction of biochemical markers and symptoms resulting from image guided percutaneous administration of PV-10 in up to 12 participants with mNET of the liver not amenable to resection or other potentially curative therapy. The Target Lesion(s) as defined by the interventional radiologist must be a uni-dimensionally measurable lesion with longest diameter between 1.0cm and 3.9cm as measured. The primary endpoint is safety. Secondary endpoints include objective response rate (ORR), target lesion SSTR and biochemical response. ORR is assessed by contrast enhanced CT and 68Ga-DOTATATE PET standardised uptake value (SUV) allows SSTR expression to be used as a surrogate for tumour viability. In addition to characterizing direct effect of PV-10 in injected lesions, response of uninjected bystander lesions is evaluated by CT and PET to characterize potential systemic benefit. Integration of patient-reported outcome (QLQ-GI.NET21), serum biomarker (CgA) and objective response (PET) data will allow testing of concordance between independent indicators of clinical benefit.
Clinical trial identification
NCT02693067.
Legal entity responsible for the study
Provectus Biopharmaceuticals.
Funding
Provectus Biopharmaceuticals.
Editorial Acknowledgement
Disclosure
E.A. Wachter, D. Sarson: Employment: Provectus Biopharmaceuticals. All other authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract